S. 4333 · 117th Congress · Senate

CLEAR Act

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
May 26, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act

This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.

Action Timeline

2
  1. MAY 26, 2022IntroReferral

    Introduced in Senate

  2. MAY 26, 2022IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: May 26, 2022

Active